Answers are grounded in this paper and cite their sources.
A combination of a MEK/ERK-signaling inhibitor and three chromatin-remodeling molecules enhances generation of platelet-producing megakaryocytes in vitro , possibly through direct reprogramming.
No takes yet. Share an insight, caveat, or question.
Johan Flygare (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: